KSQ Therapeutics closes $80M Series C for cell therapy developed with CRISPR-based platform https://t.co/09wio39xtk
— Marisa Peer (@PeerMarisa) September 28, 2018
from Twitter https://twitter.com/PeerMarisa
September 28, 2018 at 08:09AM
Friday, September 28, 2018
KSQ Therapeutics closes $80M Series C for cell therapy developed with CRISPR-based platform https://t.co/09wio39xtk
from Twitter https://twitter.com/PeerMarisa
September 28, 2018 at 08:09AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment